MedPath

ong-term beta-blocker therapy after acute myocardial infarctio

Not Applicable
Recruiting
Conditions
Diseases of the circulatory system
Registration Number
KCT0005903
Lead Sponsor
Samsung Medical Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
2500
Inclusion Criteria

Male or female, 19 years of age or older
- Diagnosed with acute myocardial infarction regardless of the time of myocardial infarction and has been treated for beta-blockers for more than a year
- Signed Informed Consent Form

Exclusion Criteria

- less than 40% left ventricular blood pressure or has never had a cardiac ultrasonography in cardiac ultrasonography since an acute myocardial infarction.
- Medication Therapy of heart failure
-contraindications to beta blockers
i)prior history of symptomatic asthma or chronic obstructive pulmonary disease
ii)Patients with a history of 2-degree, 3-degree, or artificial pacemaker
iii)If the investigator decision to used not beta-blockers
-If the life anticipation 1year under, or Poor protocol compliance
-History of atrial fibrillation
-pregnant and breast-feeding

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Major adverse cardiovascular events [MACE], a composite of all-cause death, myocardial infarction [MI], hospitalization for heart failure
Secondary Outcome Measures
NameTimeMethod
2 Years of all-cause Death After Random Allocation;2 Years of Cardiac death After Random Allocation;2 Years of myocardial infarction After Random Allocation;2 Years of All-cause hospitalizations After Random Allocation;2 Years of heart failure hospitalizations After Random Allocation;2 Years of Acute coronary syndrome hospitalizations After Random Allocation;2 Years of death or myocardial infarction After Random Allocation;2 Years of Cardiac death or myocardial infarction After Random Allocation;2 Years of myocardial infarction or heart failure hospitalizations After Random Allocation;2 Years of all re-CAG After Random Allocation;2 Years of myocardial infarction or all re-CAG After Random Allocation;2 Years of Cardiac death, myocardial infarction or all re-CAG After Random Allocation;2 Years of left ventricular implementation rate After Random Allocation;NT-proBNP at 2years;total medical expenses;quality of life scale;side effects of beta blocker
© Copyright 2025. All Rights Reserved by MedPath